Nebenwirkungen · Shingrix
Shingrix suspension for injection in pre-filled syringe Herpes zoster vaccine (recombinant, adjuvanted) · Abschnitt 4.8 · PDF-Seite 24
HOS-137989 · Präparat HOS-098121
Overall, there was a higher incidence of some adverse reactions in younger age groups: - studies in IC adults ≥ 18 years of age (pooled analysis): the incidence of pain at the injection site, fatigue, myalgia, headache, shivering and fever was higher in adults aged 18-49 years compared to those aged 50 years and above. - studies in adults ≥ 50 years of age (pooled analysis): the incidence of myalgia, fatigue, headache, shivering, fever and gastrointestinal symptoms was higher in adults aged 50-69 years compared to those aged 70 years and above.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-20T02:00:00Z · SHA-256 85082087d1e78d824692b73311f74bd22f2c91f3bb63e85a50437dd6319c83bc · Passage 2deea421755b4748e9bae8ef0c6596d1cad60a5ebc2d8442ac42502a8deea980 · Zeichen 776–1338 im Abschnitt